Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Go back to Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: PLRX) Delayed: 1.12 +0.01 (0.90%)
Previous Close $1.11    52 Week High
Open $1.12    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.12    EPS
Volume 278